The Junk-to-Grade Playbook: Why Teva’s Upgrade Is a Signal, Not a Story
Teva's BBB- upgrade from Fitch on May 18 signals a new M&A-ready posture—and reveals a playbook other over-leveraged pharma...
Investment Grade
Teva's BBB- upgrade from Fitch on May 18 signals a new M&A-ready posture—and reveals a playbook other over-leveraged pharma...